Cargando…
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
Autores principales: | Audisio, Marco, Buttigliero, Consuelo, Turco, Fabio, Delcuratolo, Marco Donatello, Pisano, Chiara, Parlagreco, Elena, Di Stefano, Rosario Francesco, Di Prima, Lavinia, Crespi, Veronica, Farinea, Giovanni, Cani, Massimiliano, Tucci, Marcello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139766/ https://www.ncbi.nlm.nih.gov/pubmed/35626651 http://dx.doi.org/10.3390/cells11101614 |
Ejemplares similares
-
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond
por: Audisio, Alessandro, et al.
Publicado: (2022) -
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside
por: Ungaro, Antonio, et al.
Publicado: (2022) -
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
por: Turco, Fabio, et al.
Publicado: (2023) -
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy
por: Turco, Fabio, et al.
Publicado: (2022) -
Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives
por: Zichi, Clizia, et al.
Publicado: (2017)